Variant report
Variant | nsv981142 |
---|---|
Chromosome Location | chr6:49217878-49220902 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537170512 | chr6:49220082-49220083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181851822 | chr6:49220104-49220105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574085469 | chr6:49220108-49220109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557375507 | chr6:49220112-49220113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs377077289 | chr6:49220133-49220134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371215680 | chr6:49220140-49220141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115188215 | chr6:49220153-49220154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201952284 | chr6:49220199-49220200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553342977 | chr6:49220212-49220213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138751726 | chr6:49220231-49220232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186187344 | chr6:49220258-49220259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62411887 | chr6:49220261-49220262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545974573 | chr6:49220280-49220281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571006567 | chr6:49220320-49220321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs519426 | chr6:49220329-49220330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs519217 | chr6:49220411-49220412 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs188501093 | chr6:49220441-49220442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371085370 | chr6:49220464-49220465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528124741 | chr6:49220655-49220656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528688027 | chr6:49220662-49220663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541971603 | chr6:49220720-49220721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141854976 | chr6:49220727-49220728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181312284 | chr6:49220729-49220730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562063914 | chr6:49220747-49220748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533329077 | chr6:49220764-49220765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551924427 | chr6:49220785-49220786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185281277 | chr6:49220795-49220796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76416894 | chr6:49220813-49220814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567655836 | chr6:49220846-49220847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138821626 | chr6:49220866-49220867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553279730 | chr6:49220871-49220872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190972275 | chr6:49220883-49220884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116201706 | chr6:49220893-49220894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557076153 | chr6:49220895-49220896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:49220000-49221000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr6:49220400-49221000 | Enhancers | NHEK | skin |
3 | chr6:49220400-49221400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr6:49220400-49221400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr6:49220600-49221000 | Enhancers | HMEC | breast |